Kaneko, M.K.; Suzuki, H.; Ohishi, T.; Nakamura, T.; Yanaka, M.; Tanaka, T.; Kato, Y.
Antitumor Activities of a Humanized Cancer-Specific Anti-HER2 Monoclonal Antibody, humH2Mab-250 in Human Breast Cancer Xenografts. Int. J. Mol. Sci. 2025, 26, 1079.
https://doi.org/10.3390/ijms26031079
AMA Style
Kaneko MK, Suzuki H, Ohishi T, Nakamura T, Yanaka M, Tanaka T, Kato Y.
Antitumor Activities of a Humanized Cancer-Specific Anti-HER2 Monoclonal Antibody, humH2Mab-250 in Human Breast Cancer Xenografts. International Journal of Molecular Sciences. 2025; 26(3):1079.
https://doi.org/10.3390/ijms26031079
Chicago/Turabian Style
Kaneko, Mika K., Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Miyuki Yanaka, Tomohiro Tanaka, and Yukinari Kato.
2025. "Antitumor Activities of a Humanized Cancer-Specific Anti-HER2 Monoclonal Antibody, humH2Mab-250 in Human Breast Cancer Xenografts" International Journal of Molecular Sciences 26, no. 3: 1079.
https://doi.org/10.3390/ijms26031079
APA Style
Kaneko, M. K., Suzuki, H., Ohishi, T., Nakamura, T., Yanaka, M., Tanaka, T., & Kato, Y.
(2025). Antitumor Activities of a Humanized Cancer-Specific Anti-HER2 Monoclonal Antibody, humH2Mab-250 in Human Breast Cancer Xenografts. International Journal of Molecular Sciences, 26(3), 1079.
https://doi.org/10.3390/ijms26031079
